Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring handicap in multiple sclerosis.

A J Thompson1

  • 1Department of Clinical Neurology, Institute of Neurology, Queen Square, London WC1N 3BG, UK.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|September 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B.

The Journal of infectious diseases·2025
Same author

Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial.

Journal of viral hepatitis·2025
Same author

Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B.

Alimentary pharmacology & therapeutics·2025
Same author

New insights into the effects of ethylene on ABA catabolism, sweetening and dormancy in stored potato tubers.

Postharvest biology and technology·2021
Same author

Direct Measurement of Single-Molecule Ligand-Receptor Interactions.

The journal of physical chemistry. B·2020
Same author

Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2019
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Participation, formerly known as handicap, significantly impacts individuals with Multiple Sclerosis (MS). Monitoring this aspect is crucial for evaluating rehabilitation strategies and improving patient outcomes in MS care.

Area of Science:

  • Rehabilitation Medicine
  • Neurology
  • Social Sciences

Background:

  • Handicap, soon to be renamed participation, is a critical but under-researched aspect of disease impact.
  • Multiple Sclerosis (MS) significantly affects individuals' employment, relationships, transport, and social integration.
  • Existing validated tools for measuring handicap are scarce, with the London Handicap Scale suitable mainly for group comparisons.

Purpose of the Study:

  • To highlight the importance of monitoring handicap (participation) in Multiple Sclerosis (MS) patients.
  • To emphasize the relevance of handicap assessment in evaluating the effectiveness of rehabilitation strategies for MS.
  • To address the need for better tools to measure handicap in the context of chronic diseases like MS.

Main Methods:

Related Experiment Videos

  • Literature review on handicap measurement in chronic diseases.
  • Analysis of the relevance of handicap in Multiple Sclerosis (MS).
  • Discussion of existing measurement tools and their limitations.

    • Main Results:

    • Handicap is a key outcome measure in chronic neurological conditions like MS.
    • The London Handicap Scale is a current, albeit limited, tool for group assessment.
    • There is a need for validated, individual-focused handicap assessment tools in MS.

    Conclusions:

    • Monitoring handicap (participation) is essential for individuals with MS.
    • Handicap assessment is particularly valuable for evaluating MS rehabilitation programs.
    • Further development of measurement tools for handicap in MS is warranted.